The 2020–2022 SPAC wave produced hundreds of newly public companies; by 2026 many of those issuers are past the initial volatility and now face real tests of execution, capital adequacy and disclosure quality. For investors, post‑SPAC stocks require a tailored due‑diligence process: the de‑SPAC transaction changes capital structure, introduces sponsor economics and often leaves companies with pro‑forma financials that warrant adjustment.

Why post‑SPAC investing needs a distinct framework

SPAC mergers create unique structural features—sponsor promote, warrant overhang, PIPE financing, and sometimes rapid follow‑on equity raises—that materially affect valuation and downside risk. Unlike companies that follow the traditional IPO path, many de‑SPAC firms went public with optimistic projections and limited operating histories as public companies. That makes a methodical, filing‑driven evaluation essential.

How to approach a post‑SPAC company: nine practical steps

1. Start with the deal documents: read the S‑4, proxy and 8‑K

  • Locate the S‑4 (or Form S‑1 if applicable), the definitive proxy, and the closing 8‑K on EDGAR—these contain the pro‑forma balance sheet, quantum of cash received at close, PIPE investor terms, and sponsor roll‑overs.
  • Extract: cash held in trust at closing, fees paid to sponsor, warrants issued, and any earnouts or contingent consideration.
  • Why it matters: the headline “cash on the balance sheet” in press releases can be overstated if a portion is restricted, earmarked for redemption, or subject to indemnities.

2. Reconcile pro‑forma financials vs. audited historicals

Pro‑forma statements often remove one‑time charges, related‑party payments and include revenue assumptions. Build an “investor adjusted” P&L that:

  1. Starts with audited/GAAP historicals from the last annual 10‑K.
  2. Adds or removes pro‑forma adjustments the company used to justify its projections (label each as recurring vs. non‑recurring).
  3. Notes related‑party revenue or expense items and how they are expected to change post‑close.

Use a one‑page reconciliation table to compare GAAP, pro‑forma, and investor‑adjusted EBITDA and revenue—this is your sanity check on management’s growth claims.

3. Map the capital structure and calculate free float

  • Pull shares outstanding, outstanding warrants, convertible instruments, and the sponsor promote. Be explicit: list common shares, public warrants, sponsor warrants, options, and PIPE lockups.
  • Calculate free float (shares likely to trade): free float = total outstanding shares – shares held by locked‑up insiders and strategic PIPE holders (if non‑trading restricted).
  • Why: a small free float plus large warrant and option overhang magnifies price moves and can produce abrupt dilution when instruments are exercised.

4. Check insider alignment and lockup schedules

Key questions:

  • What percent of founder and management equity rolled into the combined company? A high rollover can signal alignment; rapid insider selling later is a red flag.
  • When do different lockups expire? Typical sponsor/insider lockups range 6–12 months, but PIPE investors often have staggered restrictions.
  • Use SEC Form 4 to track insider sales; post‑lockup dumping is one of the most common catalysts for share price weakness.

5. Quantify cash runway and expected dilution

Estimate the company’s burn rate from the most recent quarterly filing and calculate runway:

Runway (months) = Cash and Cash Equivalents / Monthly net cash outflow

Include committed but not‑yet‑drawn debt, and any covenant‑linked tranches or contingent equity commitments. If runway under 12 months, determine likely funding channels—follow‑on equity, warrants being exercised, or debt—and model dilution scenarios for each.

6. Test revenue quality and execution milestones

  • For growth companies, ask: are revenues contracted (signed contracts, recurring subscriptions), or mainly forward‑looking bookings and letters of intent?
  • For product or manufacturing businesses (e.g., EVs, medtech), validate shipment schedules, customer deposits, and third‑party audits where available.
  • Check customer concentration—single customers representing >20–30% of revenue materially increase operational risk.

7. Inspect governance, auditor history and disclosure quality

Review audit opinions, any going concern footnotes, and auditor switches. Frequent auditor changes, related‑party note obscurity, or late filings are red flags. Also review board composition and whether independent directors are truly independent or tied to the SPAC sponsor.

8. Build scenario valuations—don’t rely on headline multiples

Construct three scenarios (bear, base, bull) that vary revenue growth, gross margins, and capital raises. For each scenario show:

  • Enterprise value implied by current market cap and net debt/pro forma cash.
  • Implied forward revenue multiple and required CAGR to justify current market pricing.
  • Share dilution under modeled capital raises.

Example: if current market cap implies a 10x 2027 revenue multiple, but the base case only supports 3x, the gap identifies downside risk and return expectations.

9. Monitor market structure signals and derivative risk

Look at options open interest and short interest as gauges of market positioning. High call OI vs. puts can indicate retail speculative interest, while high short interest may flag skepticism but also risk of squeezes. For thinly traded post‑SPACs, options are often illiquid—watch implied volatility carefully.

A short walkthrough: hypothetical "AeroVolt" (illustrative)

Assume AeroVolt merged via SPAC in 2022 and reports at-close cash of $250m. Recent filings show quarterly cash burn of $30m and commitments for a $100m contingent tranche if certain delivery milestones are met.

  • Runway = 250 / 30 ≈ 8.3 months. With the contingent tranche not guaranteed, realistic runway ≈ 8 months.
  • If management projects breakeven in 18 months, AeroVolt must raise new capital—model both a 10%‑equity raise and a 25%‑equity raise and compute resulting dilution.
  • Check lockups: insiders hold 40% and half of that unlocks in month 9. If lockup expiry coincides with a required raise, dilution plus insider selling could double downside.

This simple exercise highlights how short runway plus concentrated insider holdings can create a confluence of dilution risk and selling pressure that outweighs long‑term growth narratives.

Sources and tools

  • EDGAR (SEC filings): S‑4, 8‑K, Form 10/10‑K, Form 4 for insider trading
  • Company investor presentations and transcript archives for management guidance and milestone dates
  • Financial data platforms (Yahoo Finance, Koyfin, Bloomberg/Refinitiv for institutional users) for float, short interest and options OI
  • Simple spreadsheet modeling—build a one‑page summary with cash, runway, dilution scenarios and valuation multiples

Red flags checklist

  • Very short cash runway (12 months) with no clear committed financing
  • Opaque related‑party transactions or pro‑forma adjustments that materially improve results
  • High insider/economic sponsor concentration with imminent lockup expiries
  • Large warrant or option overhang that can be exercised at low strike prices, diluting common shareholders
  • Frequent disclosure delays, auditor changes, or restatements

Practical allocation and trade management rules

Given the asymmetric risk, many experienced investors use conservative position sizing and time‑staged exposure:

  • Initial position: 0.5–1.5% of portfolio in speculative post‑SPACs, size depending on confidence in filings and runway.
  • Milestone scaling: add on verified execution (e.g., confirmed deliveries, audited revenue recognition) rather than on hype.
  • Stop rules: define a maximum loss threshold tied to fundamentals (e.g., a financing failure or missed delivery milestone), not just price action.

Bottom line

Post‑SPAC companies can offer high upside but also concentrated downside risk driven by transaction mechanics and execution uncertainty. The strongest edge for a retail investor is disciplined, filing‑driven due diligence: reconcile pro‑forma claims with audited history, quantify runway and dilution, understand lockup timing, and value using scenario models. In 2026, the winners among the SPAC cohort will be those that converted optimistic promises into repeatable, audited revenue and stable capital structures—invest only where the numbers and the governance align with the story.